• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人干扰素α2b在溶液中的聚集:技术说明

Aggregation of recombinant human interferon alpha 2b in solution: technical note.

作者信息

Ruiz Llamil, Aroche Kethia, Reyes Nuria

机构信息

Center for Genetic Engineering and Biotechnology, PO Box 6162, Havana, Cuba.

出版信息

AAPS PharmSciTech. 2006;7(4):99. doi: 10.1208/pt070499.

DOI:10.1208/pt070499
PMID:17285753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750336/
Abstract

Sodium phosphate buffer increased the aggregation of rhIFN-α2b in the range of 1.55 to 1.810 day, as determined by SDS/PAGE under reduced and nonreduced conditions. In contrast, sodium citrate buffer decreased the aggregation rate of this cytokine, as compared with those samples in sodium phosphate buffer. Results from sodium citrate-phosphate buffer were very similar to those obtained with sodium citrate solutions. On the other hand, EDTA Na×2HO reduced the aggregation rate of rhIFN-α2b, showing an aggregation kinetic constant in the range of 0.52 to 0.75×10 day. Polysorbates 20 and 80 were less effective than the chelating agent in preventing this degradation pathway. Additionally, metal ions (Zn and Cu) increased the aggregation kinetic constant of rhIFN-α2b, probably through undetermined metal-catalyzing reactions. Taken together, these data can be useful for the development of new formulations containing rhIFN-α2b as an active ingredient.

摘要

在还原和非还原条件下通过SDS/PAGE测定,磷酸钠缓冲液在1.55至1.810天范围内增加了重组人干扰素α2b(rhIFN-α2b)的聚集。相比之下,与磷酸钠缓冲液中的样品相比,柠檬酸钠缓冲液降低了这种细胞因子的聚集速率。柠檬酸盐 - 磷酸盐缓冲液的结果与柠檬酸钠溶液的结果非常相似。另一方面,乙二胺四乙酸二钠(EDTA Na×2H₂O)降低了rhIFN-α2b的聚集速率,其聚集动力学常数在0.52至0.75×10⁻³天范围内。聚山梨酯20和80在防止这种降解途径方面比螯合剂效果差。此外,金属离子(锌和铜)可能通过未确定的金属催化反应增加了rhIFN-α2b的聚集动力学常数。综上所述,这些数据对于开发含有rhIFN-α2b作为活性成分的新制剂可能是有用的。

相似文献

1
Aggregation of recombinant human interferon alpha 2b in solution: technical note.重组人干扰素α2b在溶液中的聚集:技术说明
AAPS PharmSciTech. 2006;7(4):99. doi: 10.1208/pt070499.
2
Physical stability of albinterferon-α(2b) in aqueous solution: effects of conformational stability and colloidal stability on aggregation.阿巴他赛在水溶液中的物理稳定性:构象稳定性和胶体稳定性对聚集的影响。
J Pharm Sci. 2012 Aug;101(8):2702-19. doi: 10.1002/jps.23215. Epub 2012 Jun 6.
3
Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.重组人干扰素α-2b在无血清白蛋白的水溶液中的长期稳定性
Int J Pharm. 2003 Oct 2;264(1-2):57-72. doi: 10.1016/s0378-5173(03)00388-0.
4
Hybrid (BDBB) interferon-alpha: preformulation studies.杂交(BDBB)α干扰素:处方前研究
Int J Pharm. 1999 Oct 5;187(2):259-72. doi: 10.1016/s0378-5173(99)00124-6.
5
Stability of albumin-free interferon alfa-2b for 42 days.无白蛋白干扰素α-2b 42天的稳定性
Am J Health Syst Pharm. 1998 Aug 1;55(15):1602-5. doi: 10.1093/ajhp/55.15.1602.
6
Influence of bovine serum albumin on the secondary structure of interferon alpha 2b as determined by far UV circular dichroism spectropolarimetry.
Biologicals. 2010 Mar;38(2):314-20. doi: 10.1016/j.biologicals.2009.11.010. Epub 2009 Dec 23.
7
[Obtaining and characteristics of domestic preparation interferon alpha-2b with prolonged effect].[长效国产重组干扰素α-2b的制备及特性]
Ukr Biokhim Zh (1999). 2008 Nov-Dec;80(6):92-100.
8
Some factors affecting the stability of interferon alpha 2b in solution.一些影响干扰素α-2b溶液稳定性的因素。
Biologicals. 2006 Mar;34(1):15-9. doi: 10.1016/j.biologicals.2005.07.002. Epub 2005 Sep 26.
9
Mechanisms controlling protein release from lipidic implants: effects of PEG addition.控制脂质植入物中蛋白质释放的机制:聚乙二醇添加的影响。
J Control Release. 2007 Apr 2;118(2):161-8. doi: 10.1016/j.jconrel.2006.11.001. Epub 2006 Nov 11.
10
[Interferon alpha-2b modified with polyethylene glycol].聚乙二醇修饰的干扰素α-2b
Sheng Wu Gong Cheng Xue Bao. 2008 Sep;24(9):1658-63.

引用本文的文献

1
Electrostatics Drive Oligomerization and Aggregation of Human Interferon Alpha-2a.静电作用驱动人干扰素 α-2a 的寡聚化和聚集。
J Phys Chem B. 2021 Dec 23;125(50):13657-13669. doi: 10.1021/acs.jpcb.1c07090. Epub 2021 Dec 13.
2
Stability of protein pharmaceuticals: an update.蛋白质类药物的稳定性:最新进展。
Pharm Res. 2010 Apr;27(4):544-75. doi: 10.1007/s11095-009-0045-6. Epub 2010 Feb 9.

本文引用的文献

1
Stability of Ala 125 recombinant human interleukin-2 in solution.丙氨酸125重组人白细胞介素-2在溶液中的稳定性
J Pharm Pharmacol. 2005 Jan;57(1):31-7. doi: 10.1211/0022357055182.
2
Long-term stabilization of recombinant human interferon alpha 2b in aqueous solution without serum albumin.重组人干扰素α-2b在无血清白蛋白的水溶液中的长期稳定性
Int J Pharm. 2003 Oct 2;264(1-2):57-72. doi: 10.1016/s0378-5173(03)00388-0.
3
Peroxide formation in polysorbate 80 and protein stability.聚山梨醇酯80中过氧化物的形成与蛋白质稳定性
J Pharm Sci. 2002 Oct;91(10):2252-64. doi: 10.1002/jps.10216.
4
Cancer immunotherapy: the interferon-alpha experience.癌症免疫疗法:α干扰素的经验
Semin Oncol. 2002 Jun;29(3 Suppl 7):18-26. doi: 10.1053/sonc.2002.33078.
5
Purification and conformational properties of a human interferon alpha2b produced in Escherichia coli.在大肠杆菌中产生的人干扰素α2b的纯化及构象特性
Biotechnol Appl Biochem. 2001 Jun;33(3):173-82. doi: 10.1042/ba20010001.
6
Instability, stabilization, and formulation of liquid protein pharmaceuticals.液体蛋白质药物的不稳定性、稳定性及制剂
Int J Pharm. 1999 Aug 20;185(2):129-88. doi: 10.1016/s0378-5173(99)00152-0.
7
Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions.吐温通过疏水相互作用保护重组人生长激素免受搅拌诱导的损伤。
J Pharm Sci. 1998 Dec;87(12):1554-9. doi: 10.1021/js980175v.
8
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.单用干扰素α-2b或联合利巴韦林治疗慢性丙型肝炎复发。国际肝炎介入治疗组
N Engl J Med. 1998 Nov 19;339(21):1493-9. doi: 10.1056/NEJM199811193392102.
9
Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition.部分折叠多肽链的特异性聚集:包涵体组成的分子基础。
Nat Biotechnol. 1996 Oct;14(10):1283-7. doi: 10.1038/nbt1096-1283.
10
Molecular and biologic characterization of recombinant interferon-alpha2b.
Semin Oncol. 1997 Jun;24(3 Suppl 9):S9-41-S9-51.